Category: Corporate

07 May 2020

Cetilar® obtains Play Sure Doping Free certification and PharmaNutra launches a new advertising campaign

The No Doping Life association assigns the Play Sure Doping Free stamp to Cetilar® and ApportAL® products, and the company […]

29 April 2020

Four new distribution agreements in EU, Asia and Latin America

Despite the COVID-19 emergency, the PharmaNutra Group is still strengthening its international presence through new trade agreements signed in Romania, […]

15 April 2020

Pfizer invests in PharmaNutra’s Sucrosomial® Technology

The innovative Sucrosomial® Magnesium developed by the PharmaNutra Group is one of the main ingredients of the new Multicentrum MyMAG […]

03 April 2020

Sales figures growing for the first quarter 2020

The Group recorded a significant +15% on the Italian market in the first three months of the current year, thanks […]

25 March 2020

Two news patents approved in India and USA

The Group obtains approval of the Cetilar® patent in the USA and new prospects unfold for SiderAL® in India thanks to […]

23 March 2020

Double figure growth continues for PharmaNutra S.p.A.

The Board of Directors approves the draft balance sheet and consolidated financial statement as of 31 December 2019. […]

20 March 2020

COVID-19 emergency: a message from PharmaNutra

As we all know, the spread of COVID-19 has led to a series of restrictive measures being taken by the […]

10 March 2020

PharmaNutra supporting the National Healt Service in the Covid-19 emergency

The Group will supply the products SiderAL® H and ApportAL® free of charge to the intensive care units of all […]

06 March 2020

ApportAL®: PharmaNutra launches the new marketing campaign

At this complex time for the market, PharmaNutra is strengthening its investment plan with the launch of a new campaign. […]

07 February 2020

New international agreements for the distribution of SiderAL®

The Group communicates that it has signed new agreements with Casa Marzam S.A. and with Zentiva K.S. to distribute its […]

16 January 2020

PharmaNutra participates in the second edition of Mediobanca’s Italian Mid Cap Conference

The Group’s senior management presented its results and new development prospects to the financial community, which met for the Italian […]

08 January 2020

IQVIA-FederSalus: SiderAL® Forte is the market’s number one product in Italy

The food supplement market is growing in Italy and SiderAL® Forte 20 capsules is the most sold nutritional supplement in […]

19 December 2019

Mediobanca starts PharmaNutra share coverage

Publication of the start of coverage survey drafted by Mediobanca; declaring a target price at €24.50. PharmaNutra S.p.A. has […]

28 November 2019

New patents approved and international agreement for PharmaNutra

The Group obtains approval of two new patents for the Sucrosomial® Technology and signs a distribution agreement for the SiderAL® […]

22 October 2019

PharmaNutra at the Aim Italia Conference driven by the positive analyst forecasts

Yesterday in London, the key event focusing on Italian companies in the AIM segment. BUY rating with increased target price […]

17 September 2019

Results of the first semester of 2019: growth in double figures confirmed

The financial performance of the Group have been consolidated thanks to the scientific achievements of the technology Sucrosomial®, the constant […]

10 September 2019

New agreement with WERT Philippines for the SiderAL® range

Expansion continues on the Asian markets for the range containing Sucrosomial® Iron. From January to September an impressive 9 new […]

28 August 2019

SiderAL®: new agreement for distribution in Taiwan

PharmaNutra S.p.A. signs a new agreement for the distibution of the SiderAL® line in Taiwan. HONG CHI Biotech will be the […]

02 August 2019

PharmaNutra: historical month-based sales record in Italy

Around 400,000 units sold in July A new historical record for PharmaNutra S.p.A.: for the first time, in […]

29 July 2019

PharmaNutra anticipates information on the preliminary consolidated revenues of the first half of 2019

The Group’s growth trend is confirmed and it announces the purchase of the building that will hold its first own […]

16 July 2019

PharmaNutra S.p.A.: results come from research

The PharmaNutra group continues its rapid growth, with double-digit sales increases in the first six months of 2019, thanks to […]

< 1 2 3 4 … 7 >